190 related articles for article (PubMed ID: 23153988)
21. Clinical value of whole-body F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with carcinoma of unknown primary.
Wang G; Wu Y; Zhang W; Li J; Wu P; Xie C
J Med Imaging Radiat Oncol; 2013 Feb; 57(1):65-71. PubMed ID: 23374557
[TBL] [Abstract][Full Text] [Related]
22. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
[TBL] [Abstract][Full Text] [Related]
23. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
24. Detection of skeletal muscle metastasis: torso FDG PET-CT versus contrast-enhanced chest or abdomen CT.
So Y; Yi JG; Song I; Lee WW; Chung HW; Park JH; Moon SG
Acta Radiol; 2015 Jul; 56(7):860-6. PubMed ID: 25406434
[TBL] [Abstract][Full Text] [Related]
25. The importance of 18F-FDG PET/CT, CT and X-rays in detecting primary stage III A lung cancer and the incidence of extra thoracic metastases.
Sharma R; Tripathi M; D'Souza M; Jaimini A; Saw SK; Singh D; Mishra A; Mondal A
Hell J Nucl Med; 2009; 12(1):22-5. PubMed ID: 19330177
[TBL] [Abstract][Full Text] [Related]
26. Multiple and solitary skeletal muscle metastases on 18F-FDG PET/CT imaging.
Nocuń A; Chrapko B
Nucl Med Commun; 2015 Nov; 36(11):1091-9. PubMed ID: 26275016
[TBL] [Abstract][Full Text] [Related]
27. Skeletal muscle metastases on FDG PET/CT imaging.
Khandelwal AR; Takalkar AM; Lilien DL; Ravi A
Clin Nucl Med; 2012 Jun; 37(6):575-9. PubMed ID: 22614189
[TBL] [Abstract][Full Text] [Related]
28. Multiple metastases to skeletal muscle from carcinoma of the esophagus detected by FDG PET-CT imaging.
Heffernan E; Fennelly D; Collins CD
Clin Nucl Med; 2006 Dec; 31(12):810-1. PubMed ID: 17117081
[TBL] [Abstract][Full Text] [Related]
29. 18F FDG PET/CT in a child with gliomatosis cerebri.
Sürücü E; Mutafoğlu K; Ince D; Cakmakçı H; Demiral A; Polack BD
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):273-4. PubMed ID: 23122744
[No Abstract] [Full Text] [Related]
30. An unusual case of metastatic extramammary Paget's disease of the vulva identified by 18F-FDG PET/CT.
Treglia G; Giovannini E; Bertagna F; Giovanella L; Malaggese M
Rev Esp Med Nucl Imagen Mol; 2013; 32(6):402-3. PubMed ID: 23809514
[No Abstract] [Full Text] [Related]
31. Multiple distant muscular metastases from non-small cell lung carcinoma evidenced by 18F-FDG PET/CT.
Caobelli F; Pizzocaro C; Guerra UP
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):338-9. PubMed ID: 23809515
[No Abstract] [Full Text] [Related]
32. Polysplenia Syndrome With Splenic and Skeletal Muscle Metastases From Thyroid Carcinoma Evaluated by FDG PET/CT: Case Report and Literature Review: A Care-Compliant Article.
Li ZG; Lin ZC; Mu HY
Medicine (Baltimore); 2016 Jan; 95(4):e2532. PubMed ID: 26825891
[TBL] [Abstract][Full Text] [Related]
33. Detection of vascular malformation mimicking lung mass in 18F-FDG PET/CT.
Orsal E; Seven B; Kursad Ayan A; Sahin A; Maman A
Rev Esp Med Nucl Imagen Mol; 2013; 32(6):400-1. PubMed ID: 23669272
[No Abstract] [Full Text] [Related]
34. Uterine leiomyosarcoma metastatic to thyroid shown by
Gauthé M; Testart Dardel N; Nascimento C; Trassard M; Banal A; Alberini JL
Rev Esp Med Nucl Imagen Mol; 2017; 36(2):113-115. PubMed ID: 27777040
[TBL] [Abstract][Full Text] [Related]
35. Soft tissue metastases from differentiated thyroid cancer diagnosed by ¹⁸F FDG PET-CT.
Califano I; Quildrian S; Coduti M; Rojas Bilbao E; Otero J; Califano L
Arq Bras Endocrinol Metabol; 2013 Jun; 57(4):317-21. PubMed ID: 23828437
[TBL] [Abstract][Full Text] [Related]
36. Multiple muscle metastases from lung cancer detected by FDG PET/CT.
Yilmaz M; Elboga U; Celen Z; Isik F; Tutar E
Clin Nucl Med; 2011 Mar; 36(3):245-7. PubMed ID: 21285692
[TBL] [Abstract][Full Text] [Related]
37. Urinary bladder leiomyosarcoma: staging with 18F-FDG PET/CT.
Makis W; Rakheja R; Nahal A; Hickeson M; Lisbona R
Clin Nucl Med; 2013 May; 38(5):e218-22. PubMed ID: 23377410
[TBL] [Abstract][Full Text] [Related]
38. Subcutaneous and muscular metastasis of the colorectal cancer on F-18 FDG PET/CT.
Karyağar S; Kesici U; Karyağar S; Kece C; Güner A; Duman G; Küçütulu U
Turk J Gastroenterol; 2015 Mar; 26(2):195-6. PubMed ID: 25835124
[No Abstract] [Full Text] [Related]
39. [Positron emission tomography with 18F-fluorodeoxyglucose in patients with uterine sarcoma].
Rebollo Aguirre AC; Ramos Font C; Bellón Guardia ME; Cabello García D; Gallego Peinado M; Rodríguez Fernández A; Llamas Elvira JM
Rev Esp Med Nucl; 2007; 26(4):189-95. PubMed ID: 17662185
[TBL] [Abstract][Full Text] [Related]
40. Intramuscular metastases on FDG PET-CT: a review of the literature.
Emmering J; Vogel WV; Stokkel MP
Nucl Med Commun; 2012 Feb; 33(2):117-20. PubMed ID: 22124361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
